858.450.2800info@Sudoscan.com
SUDOSCAN® User LOGIN
Long-term monitoring using SUDOSCAN® Passer au contenu
  • About SUDOSCAN®
  • Our Company
  • Research, Media & Events
  • Contact
  • SUDOSCAN® Shop
  • Supplies
  • Se connecter
  • YouTube
Panier


Sous-total
$0.00
Les codes promo, les frais d'envoi et les taxes seront ajoutés à la caisse.
Votre panier est vide.
SUDOSCAN Logo Powered by Withings SUDOSCAN Logo Powered by Withings Sudoscan Logo white SUDOSCAN Logo Powered by Withings
  • About SUDOSCAN®
  • Our Company
  • Research, Media & Events
  • Contact
  • SUDOSCAN® Shop
  • Supplies
Se connecter Panier
Create Account
Schedule an online DEMO

Access Denied
IMPORTANT! If you’re a store owner, please make sure you have Customer accounts enabled in your Store Admin, as you have customer based locks set up with EasyLockdown app. Enable Customer Accounts
Accueil / Research, Media & Events / Long-term monitoring using SUDOSCAN®
Follow-up with SUDOSCAN · Scientific publications · 18 février, 2023

Long-term monitoring using SUDOSCAN®

Image of Sudoscan with docking station

Longitudinal Efficacy of SUDOSCAN Results Follow-up

The effectiveness of SUDOSCAN® in monitoring sudomotor function has been demonstrated in various clinical studies. A study conducted in Finland utilized SUDOSCAN to investigate the impact of physical activity on metabolic diseases and cardiovascular risk. The study found that patients with the highest level of weekly physical activity, as measured by a pedometer, experienced the most significant improvement in sudomotor function over a one-year period, resulting in the regeneration of small nerve fibers (1).

Evolution of SUDOSCAN® results among individuals enrolled in a physical activity program for 1 year.
Adapted from (1) – Table 3.

Another study conducted on type 2 diabetic subjects, shows that in bariatric surgery patient population heart rate variability, reflecting cardiac autonomic function, and sudomotor autonomic C-fiber function has been restored over time (2).

Change in primary endpoints 4, 12 and 24 weeks after bariatric surgery.
DM: diabetes mellitus, T2DM: Type 2 diabetes mellitus
Extracted from (2) – Figure 3.

These studies demonstrate that SUDOSCAN is a rapid, non-invasive, quantitative, and objective diagnostic device to follow-up autonomic neuropathy over time.

References:
(1) A. Raisanen et al (J. Tuomilehto). Sudomotor Function as a Tool for Cardiorespiratory Fitness Level Evaluation: Comparison with Maximal Exercise Capacity. Int J Environ Res Public Health. 2014 May 30;11(6):5839-48.
(2) C.M. Casellini et al (A. Vinik). Bariatric Surgery Restores Cardiac and Sudomotor Autonomic C-Fiber Dysfunction towards Normal in Obese Subjects with Type 2 Diabetes. PLoS One. 2016 May 3;11(5):e0154211.

Partager Partager sur Facebook Tweeter Tweeter sur Twitter Épingler Épingler sur Pinterest

Retour à Research, Media & Events
Invalid password
Enter
Sudoscan Logo

SUDOSCAN® is a privately-owned French medical device company.

Created in June 2005, SUDOSCAN is located in San Diego, CA, USA; the company's corporate headquarters are in Paris, France. We service all of the North and South America, The Middle East, Europe and Asia.

  • YouTube

Sudoscan

  • About SUDOSCAN®
  • Our Company
  • Research, Media & Events
  • Contact
  • SUDOSCAN® Shop
  • Supplies

Shop SUDOSCAN

  • Login
  • Create an account
  • SUDOSCAN® Shop
  • Electrodes

Resources

  • For Patients
  • For Physicians
  • SUDOSCAN® Articles
  • SUDOSCAN® Videos
  • SUDOSCAN® Image Gallery
  • Reimbursement Regulatory

CONTACT INFO:

US TERRITORIES:
SUDOSCAN Inc.
8525 Gibbs Dr. Suite 304
San Diego, CA 92123

Phone: +1 858 450 2800

INTERNATIONAL:
Impeto Medical
2 Rue Maurice Hartmann,
92130 Issy-les-Moulineaux,
France

Phone: +33 (0)7 87 20 32 03
Website: www.impeto-medical.com/

Promotional Communication. The medical devices SUDOSCAN® is cleared by the US Food and Drug Administration (FDA). The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 05/10/2023

Langue

  • English
  • Français

Devise

  • Canada (CAD $)
  • États-Unis (USD $)
  • American Express
  • Apple Pay
  • Diners Club
  • Discover
  • Google Pay
  • Mastercard
  • Shop Pay
  • Visa
© 2023 SUDOSCAN USA | Autonomic & Sudomotor Testing Device Web Development
Long-term monitoring using SUDOSCAN®